Pharma Journalist -

New Phase III clinical trial results presented at the European Congress of Endocrinology in Prague showed that Eneboparatide achieved significant improvements in calcium regulation and…
Read More...

The preliminary agenda for the 17th World ADC San Diego, taking place October 12–15, 2026, has been released, offering an exclusive first look at the scientific program for the world’s…
Read More...

GSK has announced an exclusive strategic collaboration with Sino Biopharmaceutical through its subsidiary Chia Tai Tianqing Pharmaceutical Group to accelerate the launch and…
Read More...

Bristol Myers Squibb announced that the European Commission has approved Sotyktu for the treatment of adults with active psoriatic arthritis (PsA) who have had an inadequate response or…
Read More...

The U.S. Food and Drug Administration has launched a new initiative aimed at accelerating the development of treatments for patients with unmet medical needs by exploring new uses for…
Read More...

Partner Therapeutics announced that the U.S. Food and Drug Administration has approved BIZENGRI for the treatment of adults with advanced, unresectable, or metastatic cholangiocarcinoma…
Read More...

Swiss healthcare giant Roche has signed a definitive merger agreement to acquire U.S.-based artificial intelligence pathology company PathAI, strengthening its position in the rapidly…
Read More...

Altasciences and Certara have announced a strategic partnership aimed at accelerating early-stage drug development by integrating advanced modeling and simulation technologies into…
Read More...

Italian drugmaker Angelini Pharma has agreed to acquire U.S.-based rare disease specialist Catalyst Pharmaceuticals in a cash transaction valued at approximately $4.1 billion, marking…
Read More...

Novartis has begun construction on a new radioligand therapy (RLT) manufacturing facility in Denton, Texas, as part of the company’s expanding multibillion-dollar investment in U.S.…
Read More...